This Phase II/III, randomized, comparative, double-blind, 3-arm,
outpatient, multicenter study is designed to compare effectiveness of
3TC/ZDV versus the better of ddI monotherapy versus ZDV/ddI combination
therapy with respect to HIV disease progression. The safety and
tolerance of 3TC/ZDV in ZDV naive, symptomatic children with HIV-1
infection will be evaluated.
No Sub Projects information available for 5M01RR000069-36 0625
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5M01RR000069-36 0625
Patents
No Patents information available for 5M01RR000069-36 0625
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5M01RR000069-36 0625
Clinical Studies
No Clinical Studies information available for 5M01RR000069-36 0625
News and More
Related News Releases
No news release information available for 5M01RR000069-36 0625
History
No Historical information available for 5M01RR000069-36 0625
Similar Projects
No Similar Projects information available for 5M01RR000069-36 0625